Animal models in addiction research

Drug Abuse and Addiction in Medical Illness: Causes, Consequences and Treatment

Volumn 9781461433750, Issue , 2012, Pages 73-93

  Belin, David ^a,b,c   Dalley, Jeffrey W ^d,e  

^a Laboratoire d'Oncologie Moléculaire EA3805   (France)

^b Downing Stress   (United Kingdom)

^c UNIVERSITÉ DE POITIERS   (France)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84949176086     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-3375-0_6     Document Type: Chapter

References (254)

1. Leshner AI. Addiction is a brain disease, and it matters. Science. 1997;278:45-7.
2. Leshner AI. Addiction is a brain disease. Issues in Science and Technology 2001;17(3). http://www.issues.org/17.3/leshner.htm.
3. Robinson T, Berridge K. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction. 2000;95: S91-S117.
4. Everitt BJ, Dickinson A, Robbins TW, The neuropsychological basis of addictive behaviour. Brain Res Rev. 2001;36(2-3): 129-38.
5. Everitt BJ, Robbins TW, Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci. 2005;8:1481-9.
6. Goldstein R, Volkow N. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002;159(10):1642-52.
7. Volkow N, Fowler J. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex. 2000;10(3):318-25.
8. Kreek M, Laforge K, Butelman E. Pharmacotherapy of addictions. Nat Rev Drug Discov. 2002;1:710-26.
9. Olds J, Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol. 1954;47:419-27.
10. Weeks JR. Experimental morphine addiction: method for automatic intravenous injections in unrestrained rats. Science. 1962;138(3537):143-4.
11. Kusayama T, Watanabe S. Reinforcing effects of methamphetamine in planarians. Neuroreport. 2000;11:2511-3.
12. Li H, Chaney S, Roberts IJ, Forte M, Hirsh J. Ectopic G-protein expression in dopamine and serotonin neurons blocks cocaine sensitization in Drosophila melanogaster. Curr Biol. 2000;10:211-4.
13. Wolf F, Heberlein U. Invertebrate models of drug abuse. J Neurobiol. 2002;54:161-78.
14. Carney JM, Landrum RW, Cheng MS, Seale TW. Establishment of chronic intravenous drug self-administration in the C57BL/6J mouse. Neuroreport. 1991;2:477-80.
15. Grahame NJ, Phillips TJ, Burkhart-Kasch S, Cunningham CL. Intravenous cocaine self-administration in the C57BL/6J mouse. Pharmacol Biochem Behav. 1995;51:827-34.
16. High field DA, Mead AN, Grimm JW, Rocha BA, Shaham Y. Reinstatement of cocaine seeking in 129X1/SvJ mice: effects of cocaine priming, cocaine cues and food deprivation. Psychopharmacology (Berl). 2002;161:417-24.
17. Rocha BA, Scearce-Levie K, Lucas JJ, et al. Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature. 1998;393:175-8.
18. van der Veen R, Koehl M, Abrous DN, de Kloet ER, Piazza PV, Deroche-Gamonet V. Maternal environment influences cocaine intake in adulthood in a genotype-dependent manner. PLoS ONE. 2008;3:e2245.
19. Ettenberg A, Pettit HO, Bloom FE, Koob GF. Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology. 1982;78(3):204-9.
20. Pettit HO, Ettenberg A, Bloom FE, Koob GF. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology (Berl). 1984;84:167-73.
21. Pickens R, Harris WC. Self-administration of d-amphetamine by rats. Psychopharmacologia. 1968;12:158-63.
22. De Wit H, Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology (Berl). 1981;75:134-43.
23. Risner ME, Goldberg SR. A comparison of nicotine and cocaine self-administration in the dog: fixed-ratio and progressive-ratio schedules of intravenous drug infusion. J Pharmacol Exp Ther. 1983;224:319-26.
24. Deneau G, Yanagita T, Seevers MH. Self-administration of psychoactive substances by the monkey. Psychopharmacologia. 1969;16:30-48.
25. Goldberg SR, Woods JH, Schuster CR. Morphine: conditioned increases in self-administration in rhesus monkeys. Science. 1969;166(3910):1306-7.
26. Kelleher RT, Goldberg SR. Fixed-interval responding under second-order schedules of food presentation or cocaine injection. J Exp Anal Behav. 1977;28:221-31.
27. Hoffmeister F. Progressive-ratio performance in the rhesus monkey maintained by opiate infusions. Psychopharmacology (Berl). 1979;62:181-6.
28. Rowlett JK, Wilcox KM, Woolverton WL. Self-administration of cocaine-heroin combinations by rhesus monkeys: antagonism by naltrexone. J Pharmacol Exp Ther. 1998;286:61-9.
29. Panlilio LV, Goldberg SR, Gilman JP, Jufer R, Cone EJ, Schindler CW. Effects of delivery rate and non-contingent infusion of cocaine on cocaine self-administration in rhesus monkeys. Psychopharmacology (Berl). 1998;137:253-8.
30. Nader MA, Green KL, Luedtke RR, Mach RH. The effects of benzamide analogues on cocaine self-administration in rhesus monkeys. Psychopharmacology (Berl). 1999;147:143-52.
31. Tanda G, Munzar P, Goldberg SR. Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat Neurosci. 2000;3:1073-4.
32. Nader M, Morgan D, Gage H, et al. PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci. 2006;9:1050-6.
33. Panlilio LV, Thorndike EB, Schindler CW. Cocaine selfadministration under variable-dose schedules in squirrel monkeys. Pharmacol Biochem Behav. 2006;84:235-43.
34. Ahmed SH, Koob G. Transition from moderate to excessive drug intake: change in hedonic set point. Science. 1998;282(5387): 298-300.
35. Ahmed SH, Koob G. Long-lasting increase in the set point for cocaine self-administration after escalation in rats. Psychopharmacology. 1999;146(3):303-12.
36. Belin D, Balado E, Piazza PV, Deroche-Gamonet V. Pattern of intake and drug craving predict the development of cocaine addiction- like behavior in rats. Biol Psychiatry. 2009;65:863-8.
37. Belin D, Mar A, Dalley JW, Robbins TW, Everitt BJ. High impulsivity predicts the switch to compulsive cocaine-taking. Science. 2008;320:1352-5.
38. Deroche-Gamonet V, Belin D, Piazza P. Evidence for addictionlike behavior in the rat. Science. 2004;305:1014-7.
39. Pelloux Y, Everitt BJ, Dickinson A. Compulsive drug seeking by rats under punishment: effects of drug taking history. Psychopharmacology (Berl). 2007;194:127-37.
40. Vanderschuren L, Everitt BJ. Drug seeking becomes compulsive after prolonged cocaine self-administration. Science. 2004; 305(5686):1017-9.
41. Geyer MA, Markou A, Bloom FE, Kupfer DJ. Animal models in psychatric disorders. Psychoparmacology: the fourth generation of progress. New York: Raven; 1995. p. 787-98.
42. Geyer MA, Markou A, Kenneth LD, Dennis C, Joseph TC, Charles N. The role of preclinical models in the development of psychotropic drugs. In: Davis KL, Charney D, Coyle JT, Nemeroff C, editors. Neuropsychopharmacology: the fifth generation of progress. New York: Lippincott Williams and Wilkins; 2002. p. 446-57.
43. Le Moal M. Modèles et psychopathologie Aspects théoriques. Encyclopédie Médico-Chirurgicale (Paris), Psychiatrie 1992; 37-040-C-10.
44. Koob GF, Moal ML. Neurobiology of addiction. London: Academic Press; 2005.
45. Belin D, Jonkman S, Dickinson A, Robbins TW, Everitt BJ. Parallel and interactive learning processes within the basal ganglia: relevance for the understanding of addiction. Behav Brain Res. 2008;199(1):89-102.
46. Everitt BJ, Belin D, Economidou D, Pelloux Y, Dalley JW, Robbins TW. Review: Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci. 2008;363(1507):3125-35.
47. Everitt BJ, Robbins TW. Second-order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking behaviour. Psychopharmacology. 2000;153:17-30.
48. Pelloux Y, Costentin J, Duterte-Boucher D. Differential effects of novelty exposure on place preference conditioning to amphetamine and its oral consumption. Psychopharmacology. 2004; 171:277-85.
49. Bardo M, Bevins RA. Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl). 2000;153:31-43.
50. Frenois F, Cador M, Caille S, Stinus L, Le Moine C. Neural correlates of the motivational and somatic components of naloxoneprecipitated morphine withdrawal. Eur J Neurosci. 2002;16: 1377-89.
51. Frenois F, Le Moine C, Cador M. The motivational component of withdrawal in opiate addiction: role of associative learning and aversive memory in opiate addiction from a behavioral, anatomical and functional perspective. Rev Neurosci. 2005;16:255-76.
52. Rossi NA, Reid LD. Affective states associated with morphine injections. Physiol Psychol. 1976;4:269274.
53. Tzschentke TM. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol. 2007;12:227-462.
54. Tzschentke T. Behavioral pharmacology of buprenorphine, with a focus on preclinical models of reward and addiction. Psychopharmacology. 2002;161:1-16.
55. Bossert JM, Ghitza UE, Lu L, Epstein DH, Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications. Eur J Pharmacol. 2005;526:36-50.
56. Spealman RD, Goldberg SR. Drug self-administration by laboratory animals: control by schedules of reinforcement. Annu Rev Pharmacol Toxicol. 1978;18:313-39.
57. Goldberg SR, Kelleher RT, Morse WH. Second-order schedules of drug injection. Fed Proc. 1975;34:1771-6.
58. Schindler CW, Panlilio LV, Goldberg SR. Second-order schedules of drug self-administration in animals. Psychopharmacology (Berl). 2002;163:327-44.
59. Stafford D, LeSage MG, Glowa JR. Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review. Psychopharmacology. 1998;139(3):169-84.
60. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA. 1988;85: 5274-8.
61. Wise RA. The role of reward pathways in the development of drug dependence. Pharmacol Ther. 1987;35:227-63.
62. Wise RA, Bozarth MA. Brain mechanisms of drug reward and euphoria. Psychiatr Med. 1985;3:445-60.
63. Wise RA, Bozarth MA. Brain substrates for reinforcement and drug self-administration. Prog Neuropsychopharmacol. 1981;5:467-74.
64. Berridge KC, Robinson TE, Aldridge JW. Dissecting components of reward: 'liking', 'wanting', and learning. Curr Opin Pharmacol. 2009;9(1):65-73.
65. Berridge KC. The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology (Berl). 2007;191: 391-431.
66. Everitt BJ, Wolf ME. Psychomotor stimulant addiction: a neural systems perspective. J Neurosci. 2002;22(9):3312-20.
67. Di Chiara G, Tanda G, Bassareo V, et al. Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/ extended amygdala dopamine. Ann NY Acad Sci. 1999;877: 461-85.
68. Everitt BJ, Parkinson JA, Olmstead CM, Arroyo M, Robledo P, Robbins TW. Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann NY Acad Sci. 1999;877:412-38.
69. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci. 2006;29:565-98.
70. Jones S, Bonci A. Synaptic plasticity and drug addiction. Curr Opin Pharmacol. 2005;5:20-5.
71. Robbins TW, Everitt BJ. Drug addiction: bad habits add up. Nature. 1999;398:567-70.
72. Thomas MJ, Kalivas P, Shaham Y. Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol. 2008;154:327-42.
73. Volkow ND, Fowler JS, Wang GJ, Goldstein RZ. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem. 2002; 78:610-24.
74. Kelly PH, Roberts DC. Effects of amphetamine and apomorphine on locomotor activity after 6-OHDA and electrolytic lesions of the nucleus accumbens septi. Pharmacol Biochem Behav. 1983; 19:137-43.
75. Robinson T, Kolb B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci. 1999;11:1598-604.
76. Robinson T, Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology. 2004;47 Suppl 1:33-46.
77. Robinson T, Kolb B. Persistent structural modi fications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci. 1997;17:8491-7.
78. Robinson T, Kolb B. Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse. 1999;33:160-2.
79. Kolb B, Gorny G, Li Y, Samaha AN, Robinson T. Amphetamine or cocaine limits the ability of later experience to promote structural plasticity in the neocortex and nucleus accumbens. Proc Natl Acad Sci USA. 2003;100:10523-8.
80. Chang L, Alicata D, Ernst T, Volkow N. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction. 2007;102 Suppl 1:16-32.
81. Jedynak J, Uslaner J, Esteban J, Robinson T. Methamphetamineinduced structural plasticity in the dorsal striatum. Eur J Neurosci. 2007;25:847-53.
82. Koob G, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001;24:97-129.
83. Koob G, Le Moal M. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat Neurosci. 2005;8:1442-4.
84. Koob G, Le Moal M. Addiction and the brain antireward system. Annu Rev Psychol. 2008;59:29-53.
85. Nestler EJ. The neurobiology of cocaine addiction. Sci Pract Perspect. 2005;3:4-10.
86. Nestler EJ. Is there a common molecular pathway for addiction? Nat Neurosci. 2005;8:1445-9.
87. Nestler EJ. Review. Transcriptional mechanisms of addiction: role of DeltaFosB. Philos Trans R Soc Lond B Biol Sci. 2008;363: 3245-55.
88. Nestler EJ. Epigenetic mechanisms in psychiatry. Biol Psychiatry. 2009;65:189-90.
89. Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev. 1987;94:469-92.
90. Robinson T, Berridge K. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev. 1993;18(3):247-91.
91. Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National comorbidity Survey. Exp Clin Psychopharmacol. 1994;2(3):244-68.
92. Segal DS, Weinberger SB, Cahill J, McCunney SJ. Multiple daily amphetamine administration: behavioral and neurochemical alterations. Science. 1980;207:904-7.
93. Piazza PV, Deminiere JM, Le Moal M, Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science. 1989;245:1511-3.
94. Lett BT. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berl). 1989;98:357-62.
95. Zarrindast MR, Ebrahimi-Ghiri M, Rostami P, Rezayof A. Repeated pre-exposure to morphine into the ventral pallidum enhances morphine-induced place preference: involvement of dopaminergic and opioidergic mechanisms. Behav Brain Res. 2007;181:35-41.
96. Ferrario C, Robinson T. Amphetamine pretreatment accelerates the subsequent escalation of cocaine self-administration behavior. Eur Neuropsychopharmacol. 2007;17:352-7.
97. Belin D, Deroche-Gamonet V, Jaber M. Cocaine-induced sensitization is associated with altered dynamics of transcriptional responses of the dopamine transporter, tyrosine hydroxylase, and dopamine D2 receptors in C57Bl/6 J mice. Psychopharmacology (Berl). 2007;193:567-78.
98. Pierce R, Kalivas P. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev. 1997;25(2):192-216.
99. Robinson T, Becker JB. Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. Eur J Pharmacol. 1982;85:253-4.
100. Robinson T, Becker JB, Presty SK. Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: sex differences. Brain Res. 1982;253:231-41.
101. Robinson T, Jurson PA, Bennett JA, Bentgen KM. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res. 1988;462:211-22.
102. Schlaepfer TE, Pearlson GD, Wong DF, Marenco S, Dannals RF. PET study of competition between intravenous cocaine and [11C] raclopride at dopamine receptors in human subjects. Am J Psychiatry. 1997;154:1209-13.
103. Vanderschuren L, Kalivas P. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology. 2000;151(2-3):99-120.
104. Robinson T, Berridge K. Incentive-sensitization and addiction. Addiction. 2001;96:103-14.
105. Robinson TE, Berridge KC. Addiction. Annu Rev Psychol. 2003;54:25-53.
106. Robinson TE, Berridge KC. Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci. 2008;363:3137-46.
107. Wyvell CL, Berridge K. Incentive sensitization by previous amphetamine exposure: increased cue-triggered "wanting" for sucrose reward. J Neurosci. 2001;21:7831-40.
108. Nelson A, Killcross S. Amphetamine exposure enhances habit formation. J Neurosci. 2006;26:3805-12.
109. Nordquist RE, Voorn P, de Mooij-van Malsen JG, Joosten RN, Pennartz CM, Vanderschuren LJ. Augmented reinforcer value and accelerated habit formation after repeated amphetamine treatment. Eur Neuropsychopharmacol. 2007;17:532-40.
110. Beeler J, Cao Z, Kheirbek M, Zhuang X. Loss of cocaine locomotor response in Pitx3-de ficient mice lacking a nigrostriatal pathway. Neuropsychopharmacology. 2008;34(5):1149-61.
111. Yin H, Knowlton B, Balleine B. Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning. Eur J Neurosci. 2004;19(1):181-9.
112. Yin H, Knowlton B, Balleine B. Inactivation of dorsolateral striatum enhances sensitivity to changes in the action-outcome contingency in instrumental conditioning. Behav Brain Res. 2006;166:189-96.
113. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology. 2003;168:3-20.
114. Fuchs R. Different neural substrates mediate cocaine seeking after abstinence versus extinction training: a critical role for the dorsolateral caudate-putamen. J Neurosci. 2006;26:3584-8.
115. O'Brien CP. A range of research-based pharmacotherapies for addiction. Science. 1997;278(5335):66-70.
116. Capriles N, Rodaros D, Sorge RE, Stewart J. A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl). 2003; 168:66-74.
117. Fuchs R, Tran-Nguyen LT, Specio SE, Groff RS, Neisewander JL. Predictive validity of the extinction/reinstatement model of drug craving. Psychopharmacology (Berl). 1998;135:151-60.
118. Kalivas P, Mcfarland K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl). 2003; 168:44-56.
119. De Wit H, Stewart J. Drug reinstatement of heroin-reinforced responding in the rat. Psychopharmacology (Berl). 1983;79:29-31.
120. See R, Elliott J, Feltenstein M. The role of dorsal vs ventral striatal pathways in cocaine-seeking behavior after prolonged abstinence in rats. Psychopharmacology. 2007;194:321-31.
121. Ahmed SH, Walker JR, Koob G. Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology. 2000;22(4):413-21.
122. Ahmed S, Cador M. Dissociation of psychomotor sensitization from compulsive cocaine consumption. Neuropsychopharmacology. 2006;31:563-71.
123. Goldberg SR. Comparable behavior maintained under fixed-ratio and second-order schedules of food presentation, cocaine injection or d-amphetamine injection in the squirrel monkey. J Pharmacol Exp Ther. 1973;186:18-30.
124. Goldberg SR, Morse WH, Goldberg DM. Behavior maintained under a second-order schedule by intramuscular injection of morphine or cocaine in rhesus monkeys. J Pharmacol Exp Ther. 1976;199:278-86.
125. Goldberg SR, Kelleher RT, Goldberg DM. Fixed-ratio responding under second-order schedules of food presentation or cocaine injection. J Pharmacol Exp Ther. 1981;218:271-81.
126. Tiffany ST. A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes. Psychol Rev. 1990;97:147-68.
127. Arroyo M, Markou A, Robbins TW, Everitt BJ. Acquisition, maintenance and reinstatement of intravenous cocaine self-administration under a second-order schedule of reinforcement in rats: effects of conditioned cues and continuous access to cocaine. Psychopharmacology (Berl). 1998;140:331-44.
128. Belin D, Everitt BJ. Cocaine-seeking habits depend upon dopamine- dependent serial connectivity linking the ventral with the dorsal striatum. Neuron. 2008;57:432-41.
129. Ito R, Dalley JW, Robbins TW, Everitt BJ. Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J Neurosci. 2002;22:6247-53.
130. Ito R, Robbins TW, Everitt BJ. Differential control over cocaineseeking behavior by nucleus accumbens core and shell. Nat Neurosci. 2004;7:389-97.
131. Vanderschuren L. Involvement of the dorsal striatum in cuecontrolled cocaine seeking. J Neurosci. 2005;25:8665-70.
132. Lee J. Reconsolidation and extinction of conditioned fear: inhibition and potentiation. J Neurosci. 2006;26:10051-6.
133. Burns LH, Robbins T, Everitt B. Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions of D-amphetamine. Behav Brain Res. 1993;55:167-83.
134. Cador M, Robbins TW, Everitt BJ. Involvement of the amygdala in stimulus-reward associations: interaction with the ventral striatum. Neuroscience. 1989;30(1):77-86.
135. Everitt BJ, Cador M, Robbins TW. Interactions between the amygdala and ventral striatum in stimulus-reward associations: studies using a second-order schedule of sexual reinforcement. Neuroscience. 1989;30:63-75.
136. Di Ciano P. Direct interactions between the basolateral amygdala and nucleus accumbens core underlie cocaine-seeking behavior by rats. J Neurosci. 2004;24:7167-73.
137. Everitt BJ, Hutcheson D, Ersche K, Pelloux Y, Dalley JW, Robbins TW. The orbital prefrontal cortex and drug addiction in laboratory animals and humans. Ann NY Acad Sci. 2007;1121:576-97.
138. Hutcheson DM, Everitt BJ. The effects of selective orbitofrontal cortex lesions on the acquisition and performance of cuecontrolled cocaine seeking in rats. Ann NY Acad Sci. 2003; 1003:410-1.
139. Di Ciano P, Everitt BJ. Contribution of the ventral tegmental area to cocaine-seeking maintained by a drug-paired conditioned stimulus in rats. Eur J Neurosci. 2004;19:1661-7.
140. Haber S. The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat. 2003;26:317-30.
141. Haber S, Fudge JL, McFarland NR. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci. 2000;20(6):2369-82.
142. Ikemoto S. Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev. 2007;56:27-78.
143. DSM-IV APA. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association; 2000.
144. Cacciola J, Alterman A, O'Brien CP, Mclellan A. The addiction severity index in clinical efficacy trials of medications for cocaine dependence. NIDA Res Monogr. 1997;175:182-91.
145. Kampman KM, Volpicelli JR, McGinnis DE, et al. Reliability and validity of the cocaine selective severity assessment. Addict Behav. 1998;23:449-61.
146. Mclellan A, Kushner H, Metzger D, Peters R. The fifth edition of the addiction severity index. J Subst Abuse Treat. 1992;9(3): 199-213.
147. Rikoon S, Cacciola J, Carise D, Alterman A, Mclellan A. Predicting DSM-IV dependence diagnoses from addiction severity index composite scores. J Subst Abuse Treat. 2006;31:17-24.
148. Kreek M, Nielsen D, Butelman E, Laforge K. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci. 2005;8:1450-7.
149. Teichman M, Barnea Z, Rahav G. Sensation seeking, state and trait anxiety, and depressive mood in adolescent substance users. Int J Addict. 1989;24:87-99.
150. Teichman M, Barnea Z, Ravav G. Personality and substance use among adolescents: a longitudinal study. Br J Addict. 1989;84: 181-90.
151. Adams JB, Heath AJ, Young SE, Hewitt JK, Corley RP, Stallings MC. Relationships between personality and preferred substance and motivations for use among adolescent substance abusers. Am J Drug Alcohol Abuse. 2003;29:691-712.
152. Conway K, Swendsen JD, Rounsaville BJ, Merikangas KR. Personality, drug of choice, and comorbid psychopathology among substance abusers. Drug Alcohol Depend. 2002;65:225-34.
153. Khantzian EJ. Psychiatric illness in drug abusers. N Engl J Med. 1980;302:869-70.
154. Kilpatrick DG, Sutker PB, Roitzsch JC, Miller WC. Personality correlates of polydrug abuse. Psychol Rep. 1976;38:311-7.
155. Moeller FG, Dougherty DM, Barratt ES, et al. Increased impulsivity in cocaine dependent subjects independent of antisocial personality disorder and aggression. Drug Alcohol Depend. 2002;68:105-11.
156. Moss HB. Psychopathy, aggression, and family history in male veteran substance abuse patients: a factor analytic study. Addict Behav. 1989;14:565-70.
157. Pomerleau CS, Pomerleau OF, Flessland KA, Basson SM. Relationship of Tridimensional Personality Questionnaire scores and smoking variables in female and male smokers. J Subst Abuse. 1992;4:143-54.
158. Sarramon C, Verdoux H, Schmitt L, Bourgeois M. Addiction and personality traits: sensation seeking, anhedonia, impulsivity. Encephale. 1999;25:569-75.
159. Schinka JA, Curtiss G, Mulloy JM. Personality variables and selfmedication in substance abuse. J Pers Assess. 1994;63:413-22.
160. Scour field J, Stevens DE, Merikangas KR. Substance abuse, comorbidity, and sensation seeking: gender differences. Compr Psychiatry. 1996;37:384-92.
161. Sher KJ, Bartholow BD, Wood MD. Personality and substance use disorders: a prospective study. J Consult Clin Psychol. 2000; 68:818-29.
162. Skinstad AH, Swain A. Comorbidity in a clinical sample of substance abusers. Am J Drug Alcohol Abuse. 2001;27:45-64.
163. Wills TA, Vaccaro D, McNamara G. Novelty seeking, risk taking, and related constructs as predictors of adolescent substance use: an application of Cloninger's theory. J Subst Abuse. 1994;6:1-20.
164. Zuckerman M. Sensation seeking and the endogenous de ficit theory of drug abuse. NIDA Res Monogr. 1986;74:59-70.
165. Zuckerman M. P-impulsive sensation seeking and its behavioral, psychophysiological and biochemical correlates. Neuro psychobiology. 1993;28:30-6.
166. Zuckerman M, Neeb M. Sensation seeking and psychopathology. Psychiatry Res. 1979;1:255-64.
167. Forsyth J. Anxiety sensitivity, controllability, and experiential avoidance and their relation to drug of choice and addiction severity in a residential sample of substance-abusing veterans. Addict Behav. 2003;28:851-70.
168. O'Leary TA, Rohsenow DJ, Martin R, Colby SM, Eaton CA, Monti PM. The relationship between anxiety levels and outcome of cocaine abuse treatment. Am J Drug Alcohol Abuse. 2000; 26:179-94.
169. Roberts A. Psychiatric comorbidity in white and African-American illicit substance abusers: evidence for differential etiology. Clin Psychol Rev. 2000;20:667-77.
170. Thomas McLellan A, Cacciola J, Alterman A, Rikoon S, Carise D. The addiction severity index at 25: origins, contributions and transitions. Am J Addict. 2006;15:113-24.
171. Zilberman ML, Tavares H, Hodgins DC, el-Guebaly N. The impact of gender, depression, and personality on craving. J Addict Dis. 2007;26:79-84.
172. Hanson KL, Luciana M, Sullwold K. Reward-related decisionmaking de ficits and elevated impulsivity among MDMA and other drug users. Drug Alcohol Depend. 2008;96:99-110.
173. Petry NM. Discounting of delayed rewards in substance abusers: relationship to antisocial personality disorder. Psychopharmacology (Berl). 2002;162:425-32.
174. Franques P, Auriacombe M, Tignol J. Addiction and personality. Encephale. 2000;26:68-78.
175. Chandra PS, Krishna VA, Benegal V, Ramakrishna J. High-risk sexual behaviour & sensation seeking among heavy alcohol users. Indian J Med Res. 2003;117:88-92.
176. Zuckerman M. Sensation seeking and behavior disorders. Arch Gen Psychiatry. 1988;45:502-4.
177. Zuckerman M. The psychophysiology of sensation seeking. J Personal. 1990;58:313-45.
178. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav. 1996;54:21-30.
179. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 1985;14:149-67.
180. Pelloux Y, Costentin J, Duterte-Boucher D. Anxiety increases the place conditioning induced by cocaine in rats. Behav Brain Res. 2009;197:311-6.
181. Homberg J, Van Den Akker M, Raaso H, et al. Enhanced motivation to self-administer cocaine is predicted by self-grooming behaviour and relates to dopamine release in the rat medial prefrontal cortex and amygdala. Eur J Neurosci. 2002;15: 1542-50.
182. Bush D, Vaccarino F. Individual differences in elevated plus-maze exploration predicted progressive-ratio cocaine self-administration break points in Wistar rats. Psychopharmacology. 2007;194:211-9.
183. Henniger MS, Spanagel R, Wigger A, Landgraf R, Holter SM. Alcohol self-administration in two rat lines selectively bred for extremes in anxiety-related behavior. Neuropsychopharmacology. 2002;26:729-36.
184. Spanagel R, Montkowski A, Allingham K, et al. Anxiety: a potential predictor of vulnerability to the initiation of ethanol selfadministration in rats. Psychopharmacology (Berl). 1995;122: 369-73.
185. Chakroun N, Doron J, Swendsen J. Substance use, affective problems and personality traits: test of two association models. Encephale. 2004;30:564-9.
186. Stewart SH, Karp J, Pihl RO, Peterson RA. Anxiety sensitivity and self-reported reasons for drug use. J Subst Abuse. 1997;9:223-40.
187. Bardo M, Donohew RL, Harrington NG. Psychobiology of novelty seeking and drug seeking behavior. Behav Brain Res. 1996;77(1-2):23-43.
188. Hooks MS, Jones GH, Smith AD, Neill DB, Justice JB. Individual differences in locomotor activity and sensitization. Pharmacol Biochem Behav. 1991;38:467-70.
189. Piazza PV, Rouge-Pont F, Deminiere JM, Kharoubi M, Le Moal M, Simon H. Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Res. 1991;567: 169-74.
190. Misslin R, Cigrang M. Does neophobia necessarily imply fear or anxiety? Behav Process. 1986;12:45-50.
191. Klebaur JE, Bevins RA, Segar TM, Bardo M. Individual differences in behavioral responses to novelty and amphetamine selfadministration in male and female rats. Behav Pharmacol. 2001;12(4):267-75.
192. Bardo M, Neisewander JL, Pierce R. Novelty-induced place preference behavior in rats: effects of opiate and dopaminergic drugs. Pharmacol Biochem Behav. 1989;32:683-9.
193. Klebaur JE, Bardo M. Individual differences in novelty seeking on the playground maze predict amphetamine conditioned place preference. Pharmacol Biochem Behav. 1999;63:131-6.
194. Bardo MT, Bowling SL, Robinet PM, Rowlett JK, Lacy M, Mattingly BA. Role of dopamine D1 and D2 receptors in noveltymaintained place preference. Exp Clin Psychopharmacol. 1993;1:101-9.
195. Zuckerman M, Link K. Construct validity for the sensation-seeking scale. J Consult Clin Psychol. 1968;32:420-6.
196. Zuckerman M, Bone RN, Neary R, Mangelsdorff D, Brustman B. What is the sensation seeker? Personality trait and experience correlates of the Sensation-Seeking Scales. J Consult Clin Psychol. 1972;39:308-21.
197. Schooler C, Zahn TP, Murphy DL, Buchsbaum MS. Psychological correlates of monoamine oxidase activity in normals. J Nerv Ment Dis. 1978;166:177-86.
198. Beck LH, Bransome ED, Mirsky AF, Rosvold HE, Sarason I. A continuous performance test of brain damage. J Consult Psychol. 1956;20:343-50.
199. Bari A, Dalley JW, Robbins TW. The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats. Nat Protoc. 2008; 3(5):759-67.
200. Robbins TW. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology. 2002;163(3-4):362-80.
201. Dalley JW, Cardinal R, Robbins JW. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev. 2004;28:771-84.
202. Dalley JW, Mar A, Economidou D, Robbins TW. Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry. Pharmacol Biochem Behav. 2008;90: 250-60.
203. Dalley JW, Fryer T, Brichard L, et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science. 2007;315:1267-70.
204. Diergaarde L, Pattij T, Poortvliet I, et al. Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats. Biol Psychiatry. 2008;63:301-8.
205. Economidou D, Pelloux Y, Robbins TW, Dalley JW, Everitt BJ. High impulsivity predicts relapse to cocaine-seeking after punishment- induced abstinence. Biol Psychiatry. 2009;65(10):851-6.
206. Deminiere JM, Piazza PV, Le Moal M, Simon H. Experimental approach to individual vulnerability to psychostimulant addiction. Neurosci Biobehav Rev. 1989;13:141-7.
207. O'Brien CP, Mclellan A. Myths about the treatment of addiction. Lancet. 1996;347:237-40.
208. Stewart J, De Wit H. Reinstatement of drug taking behaviour as a method of assessing incentive motivational properties of drugs. In: Bozarth MA, editor. Assessing drug reinforcement. New York: Springer; 1987. p. 12.
209. Gawin FH. Cocaine abuse and addiction. J Fam Pract. 1989;29: 193-7.
210. Gawin FH. Cocaine addiction: psychology and neurophysiology. Science. 1991;251:1580-6.
211. Lenoir M, Ahmed S. Heroin-induced reinstatement is speci fic to compulsive heroin use and dissociable from heroin reward and sensitization. Neuropsychopharmacology. 2007;32:616-24.
212. Shalev U, Grimm JW, Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev. 2002; 54(1):1-42.
213. Piazza PV, Deminiere JM, Maccari S, Mormede P, Le Moal M, Simon H. Individual reactivity to novelty predicts probability of amphetamine self-administration. Behav Pharmacol. 1990; 1:339-45.
214. Koob GF. Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology. 2009;56 Suppl 1:18-31.
215. Shen H, Toda S, Moussawi K, Bouknight A, Zahm D, Kalivas P. Altered dendritic spine plasticity in cocaine-withdrawn rats. J Neurosci. 2009;29:2876-84.
216. Sarti F, Borgland SL, Kharazia VN, Bonci A. Acute cocaine exposure alters spine density and long-term potentiation in the ventral tegmental area. Eur J Neurosci. 2007;26:749-56.
217. Lee KW, Kim Y, Kim AM, Helmin K, Nairn AC, Greengard P. Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens. Proc Natl Acad Sci USA. 2006;103:3399-404.
218. Li Y, Acerbo M, Robinson T. The induction of behavioural sensitization is associated with cocaine-induced structural plasticity in the core (but not shell) of the nucleus accumbens. Eur J Neurosci. 2004;20:1647-54.
219. Norrholm SD, Bibb JA, Nestler EJ, Ouimet CC, Taylor JR, Greengard P. Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclindependent kinase-5. Neuroscience. 2003;116:19-22.
220. Robinson T, Gorny G, Mitton E, Kolb B. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse. 2001;39:257-66.
221. Koob GF, Nestler EJ. The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci. 1997;9:482-97.
222. Volkow ND, Wang GJ, Fowler JS, et al. Decreased striatal dopaminergic responsiveness in detoxi fied cocaine-dependent subjects. Nature. 1997;386:830-3.
223. Koob G, Weiss F. Neuropharmacology of cocaine and ethanol dependence. Recent Dev Alcohol. 1992;10:201-33.
224. Arnsten AF, Li BM. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry. 2005;57:1377-84.
225. Bassareo V, Tanda G, Di Chiara G. Increase of extracellular dopamine in the medial prefrontal cortex during spontaneous and naloxone-precipitated opiate abstinence. Psychopharmacology (Berl). 1995;122:202-5.
226. Bechara A, Damasio H. Decision-making and addiction (part I): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia. 2002;40:1675-89.
227. Bechara A, Dolan S, Hindes A. Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward? Neuropsychologia. 2002;40:1690-705.
228. Briand LA, Flagel S, Garcia-Fuster MJ, et al. Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine. Neuropsychopharmacology. 2008;33(12):2969-80.
229. Koya E, Uejima JL, Wihbey KA, Bossert JM, Hope BT, Shaham Y. Role of ventral medial prefrontal cortex in incubation of cocaine craving. Neuropharmacology. 2009;56 Suppl 1:177-85.
230. Porrino L, Lyons D. Orbital and medial prefrontal cortex and psychostimulant abuse: studies in animal models. Cereb Cortex. 2000;10:326-33.
231. Porrino L, Domer FR, Crane AM, Sokoloff L. Selective alterations in cerebral metabolism within the mesocorticolimbic dopaminergic system produced by acute cocaine administration in rats. Neuropsychopharmacology. 1988;1:109-18.
232. Schoenbaum G, Saddoris MP, Ramus SJ, Shaham Y, Setlow B. Cocaine-experienced rats exhibit learning de ficits in a task sensitive to orbitofrontal cortex lesions. Eur J Neurosci. 2004;19: 1997-2002.
233. Winstanley CA, LaPlant Q, Theobald DE, et al. DeltaFosB induction in orbitofrontal cortex mediates tolerance to cocaine-induced cognitive dysfunction. J Neurosci. 2007;27:10497-507.
234. Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev. 1998;28:309-69.
235. Koob G, Moal ML. Drug abuse: hedonic homeostatic dysregulation. Science. 1997;278(5335):52-8.
236. Schoenbaum G, Roesch M, Stalnaker T. Orbitofrontal cortex, decision- making and drug addiction. Trends Neurosci. 2006;29:116-24.
237. Schoenbaum G, Shaham Y. The role of orbitofrontal cortex in drug addiction: a review of preclinical studies. Biol Psychiatry. 2008;63(3):256-62.
238. Dickinson A, Wood N, Smith J. Alcohol seeking by rats: action or habit? Q J Exp Psychol Sect B. 2002;55:331-48.
239. Miles F, Everitt B, Dickinson A. Oral cocaine seeking by rats: action or habit? Behav Neurosci. 2003;117:927-38.
240. Porrino L. Cocaine self-administration produces a progressive involvement of limbic, association, and sensorimotor striatal domains. J Neurosci. 2004;24:3554-62.
241. Letchworth SR, Nader MA, Smith HR, Friedman DP, Porrino L. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J Neurosci. 2001;21:2799-807.
242. Jentsch JD, Taylor JR. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology. 1999;146(4): 373-90.
243. Hester R, Garavan H. Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci. 2004;24:11017-22.
244. Kirby KN, Petry NM. Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non-drugusing controls. Addiction. 2004;99:461-71.
245. Black Y. Altered attention and prefrontal cortex gene expression in rats after binge-like exposure to cocaine during adolescence. J Neurosci. 2006;26:9656-65.
246. Calu D, Stalnaker T, Franz T, Singh T, Shaham Y, Schoenbaum G. Withdrawal from cocaine self-administration produces long-lasting de ficits in orbitofrontal-dependent reversal learning in rats. Learn Mem. 2007;14:325-8.
247. Dalley J, Lääne K, Pena Y, Theobald D, Everitt B, Robbins T. Attentional and motivational de ficits in rats withdrawn from intravenous self-administration of cocaine or heroin. Psychopharmacology. 2005;182:579-87.
248. Dalley J, Theobald D, Berry D, et al. Cognitive sequelae of intravenous amphetamine self-administration in rats: evidence for selective effects on attentional performance. Neuropsychopharmacology. 2005;30:525-37.
249. George O, Mandyam C, Wee S, Koob G. Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments. Neuropsychopharmacology. 2008;33:2474-82.
250. Paine T, Olmstead M. Cocaine disrupts both behavioural inhibition and conditional discrimination in rats. Psychopharmacology (Berl). 2004;175:443-50.
251. Paine TA, Dringenberg HC, Olmstead MC. Effects of chronic cocaine on impulsivity: relation to cortical serotonin mechanisms. Behav Brain Res. 2003;147:135-47.
252. Schoenbaum G. Cocaine makes actions insensitive to outcomes but not extinction: implications for altered orbitofrontal-amygdalar function. Cereb Cortex. 2004;15:1162-9.
253. Bolla KI, Eldreth DA, London ED, et al. Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. NeuroImage. 2003;19:1085-94.
254. Porrino L, Smith HR, Nader MA, Beveridge TJ. The effects of cocaine: a shifting target over the course of addiction. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:1593-600.